Report - Sir Andrew Witty CEO - GSK0% 5% 10% 15% 20% 25% 0% 10% 20% 30% 40% Portfolio of once-a-day, easy-to-use Ellipta inhalers TRx NRx NBRx TRx NRx NBRx Closed triple: •Filed in US and

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form